Overexpression of bone morphogenetic protein-6 (BMP-6) in the epidermis of transgenic mice: inhibition or stimulation of proliferation depending on the pattern of transgene expression and formation of psoriatic lesions

Journal of Cell Biology

Volumn 135, Issue 1, 1996, Pages 227-239

  Blessing, Manfred ^a   Schirmacher, Peter ^a   Kaiser, Sibylle ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BONE MORPHOGENETIC PROTEIN;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; EPIDERMIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PSORIASIS; TRANSGENIC MOUSE;

ACANTHOSIS NIGRICANS; ANIMALS; ANIMALS, NEWBORN; ANTIGENS, CD; BONE MORPHOGENETIC PROTEINS; CELL DIFFERENTIATION; CELL DIVISION; EPIDERMIS; GENE EXPRESSION REGULATION, DEVELOPMENTAL; HUMANS; INTEGRIN ALPHA6; KERATIN-10; KERATINS; KERATOSIS; MICE; MICE, TRANSGENIC; MOUTH MUCOSA; PROMOTER REGIONS (GENETICS); PSORIASIS; RNA, MESSENGER; SKIN; STOMACH;

ANIMALIA; MUS MUSCULUS;

EID: 0029834634     PISSN: 00219525     EISSN: None     Source Type: Journal    
DOI: 10.1083/jcb.135.1.227     Document Type: Article

References (58)

1. Blessing, M., L.B. Nanney, L.E. King, C.M. Jones, and B.L.M. Hogan. 1993. Transgenic mice as a model to study the role of TGF-beta related molecules in hair follicles. Genes Dev. 7:204-215.
2. Blessing, M., L.B. Nanney, L.E. King, and B.L.M. Hogan. 1995. Chemical skin carcinogenesis is prevented in mice by the induced expression of a TGF-beta related transgene. Teratog. Carcinog. Mutagen. 15:11-21.
3. Bullard, D.C., K. Scharffetter-Kochanek, M.J. McArthur, J.G. Chosay, M.E. McBride, C.A. Montgomery, and A.L. Beaudet. 1996. A polygenic mouse model of psoriasiform skin disease in CD18-deficient mice. Proc. Natl. Acad. Sci. USA. 93:2116-2121.
4. Carey, D.E., and X. Liu. 1995. Expression of hone morphogenetic protein-6 messenger RNA in bovine growth plate chondrocytes of different size. J. Bone Miner. Res. 10:401-405.
5. Carroll, J.M., M.R. Romero, and F.M. Watt. 1995. Suprabasal integrin expression in the epidermis of transgenic mice results in developmental defects and a phenotype resembling psoriasis. Cell. 83:957-968.
6. Celeste, A.J., J.A. Iannazzi, R.C. Taylor, R.M. Hewick, V. Rosen, E.A. Wang, and J.M. Wozney. 1990. Identification of transforming growth factor beta family members present in bone-inductive protein purified from bovine bone. Proc. Natl. Acad. Sci. USA. 87:9843-9847.
7. Cheng, J., K. Turksen, Q.-C. Yu, H. Schreiber, M. Teng, and E. Fuchs. 1992. Cachexia and graft versus host-disease-type skin changes in keratin promoter-driven TNFα transgenic mice. Genes Dev. 6:1444-1456.
8. Cui, W., D.J. Fowlis, F.M. Cousins, E. Duffie, S. Bryson, A. Balmain, and R.J. Akhurst. 1995. Concerted action of TGF-beta1 and its type II receptor in control of epidermal homeostasis in transgenic mice. Genes Dev. 9:945-955.
9. Dominey, A.M., X.-J. Wang, L.E. King, L.B. Nanney, T.A. Gagne, K. Sellheyer, D.S. Bundman, M.A. Longley, J.A. Rothnagel, D.A. Greenhalgh, and D.R. Roop. 1993. Targeted overexpression of transforming growth factor alpha in the epidermis of transgenic mice elicits hyperplasia, hyperkeratosis, and spontaneous, squamous papillomas. Cell Growth Differ. 4:1071-1082.
10. Drozdoff, V., N.A. Wall, and W.J. Pledger. 1994. Expression and growth inhibitory effect of decapentaplegic Vg-related protein 6: evidence for a regulatory role in keratinocyte differentiation. Proc. Natl. Acad. Sci. USA. 91: 5528-5532.
11. Elder, J.T., G.J. Fisher, P.B. Lindquist, G.L. Bennet, M.R. Pittelkow, R.J. Coffey, L. Ellingsworth, R. Derynck, and J.J. Voorhees. 1989. Overexpression of transforming growth factor alpha in psoriatic epidermis. Science (Wash. DC). 243:811-814.
12. Fuchs, E., and H. Green. 1980. Changes in keratin gene expression during terminal differentiation of the keratinocyte. Cell. 19:1033-1042.
13. Fuchs, E., A. Stoler, R. Kopan, and M. Rosenberg. 1988. The differential expression of keratin genes in human epidermal cells. In The Biology of Wool and Hair, G.E. Rogers, P.J. Reis, K.A. Ward, and R.C. Marshall, editors. Chapman & Hall Inc., New York. 287-309.
14. Garcia, R.L., M.D. Coltrera, and A.M. Gown. 1989. Analysis of proliferative grade using anti-PCNA/cyclin monoclonal antibodies in fixed, embedded tissues compared with flow cytometric analysis. Am. J. Pathol. 134:733-739.
15. Gitelman, S.E., M.S. Kobrin, J.Q. Ye, A.R. Lopez, A. Lee, and R. Derynck. 1994. Recombinant Vgr-1/BMP-6-expressing tumors induce fibrosis and endochondral bone formation in vivo. J. Cell Biol. 126:1595-1609.
16. Gitelman, S.E., M. Kirk, Y.Q. Ye, E.H. Filvaroff, A.J. Kahn, and R. Derynck. 1995. Vgr-1/BMP-6 induces osteoblastic differentiation of pluripotential mesenchymal cells. Cell Growth Differ. 6:827-836.
17. Gottlieb, A.B., C.K. Chang, D.N. Posnett, B. Fanelli, and J.B. Tam. 1988. Detection of transforming growth factor alpha in normal, malignant, and hyperproliferative human keratinocytes. J. Exp. Med. 167:670-675.
18. 389 IL-2) suggests a primary immune, but not keratinocyte, pathogenic basis. Nat. Med. 1:442-447.
19. Guo, L., Q.-C. Yu, and E. Fuchs. 1993. Targeting expression of keratinocyte growth factor to keratinocytes elicits striking changes in epithelial differentiation in transgenic mice. EMBO (Eur. Mol. Biol. Organ.) J. 12:973-986.
20. Hammer, R.E., S.D. Maika, J.A. Richardson, J.-P. Tang, and J.D. Taurog. 1990. Spontaneous inflammatory disease in transgenic rats expressing HLA-B27 and human β2m: an animal model of HLA-B27-associated disorders. Cell. 63:1099-1112.
21. Hogan, B.L.M., F. Costatini, and E. Lacy. 1986. Manipulating the Mouse Embryo. A Laboratory Manual. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, New York.
22. Hughes, F.J., J. Collyer, M. Stanfield, and S.A. Goodman. 1995. The effects of bone morphogenetic protein-2, -4, and -6 on differentiation of rat osteoblast cells in vitro. Endocrinology. 136:2671-2677.
23. Jones, C.M., K.M. Lyons, and B.L.M. Hogan. 1991. Involvement of Bone Morphogenetic Protein-4 (BMP-4) and Vgr-1 in morphogenesis and neurogenesis in the mouse. Development (Camb.). 111:531-542.
24. Kane, C.J., A.M. Knapp, J.N. Mansbridge, and P.C. Hanawalt. 1990. Transforming growth factor-beta1 localization in normal and psoriatic epidermal keratinocytes in situ. J. Cell Physiol. 144:144-150.
25. Krueger, J.G., J.F. Krane, D.M. Carter, and A.B. Gottlieb. 1990. Role of growth factors, cytokines, and their receptors in the pathogenesis of psoriasis. J. Invest. Dermatol. 94(Suppl.):135S-140S.
26. Kupper, T.S. 1990. Immune and inflammatory processes in cutaneous tissues. Mechanisms and speculations. J. Clin. Invest. 86:1783-1789.
27. Lavker, R.M., and T.-T. Sun. 1983. Epidermal stem cells. J. Invest. Dermatol. 83:121-127.
28. Leigh, I.M., K.A. Pulford, F.C.S. Ramaekers, and E.B. Lane. 1985. Psoriasis: maintenance of an intact monolayer basal cell differentiation compartment in spite of hyperproliferation. Br. J. Dermatol. 113:53-64.
29. Lever, W.F., and G. Schaumburg-Lever. 1975. Noninfectious erythematous. papular, and squamous diseases. In Histopathology of the Skin, W.F. Lever and G. Schaumburg-Lever, editors. J.B. Lippincott Company, Philadelphia. 133-156.
30. Lyons, K.M., J.L. Grayear, S. Hashmi, P.B. Lindquist, E.Y. Chen, B.L.M. Hogan, and R. Derynck. 1989a. Vgr-1, a mammalian gene related to Xenopus Vg-1, is a member of the transforming growth factor beta gene superfamily. Proc. Natl. Acad. Sci. USA. 86:4554-4558.
31. Lyons, K.M., R.W. Pelton, and B.L.M. Hogan. 1989b. Patterns of expression of murine Vgr-1 and BMP-2a RNA suggest that transforming growth factor-beta-like genes coordinately regulate aspects of embryonic development. Genes Dev. 3:1657-1668.
32. Lyons, K.M., C.M. Jones, and B.L.M. Hogan. 1991. The DVR gene family in embryonic development. Trends Genet. 7:408-412.
33. Massague, J., J. Heino, and M. Laiho. 1991. Mechanisms of TGF-beta action. Ciba. Found. Symp. 159:51-65.
34. Nanney, L.B., R.A. Yates, and L.E. King. 1992. Modulation of epidermal growth factor receptors in psoriatic lesions during treatment with topical EGF. Invest. Dermatol. 98:296-301.
35. Nelson, W., and T.-T. Sun. 1983. The 50- and 58-kdalton keratin classes as molecular markers for stratified squamous epithelia: cell culture studies. J. Cell Biol. 6:539-548.
36. Nickoloff, B.J., G.D. Karabin, J.N. Barker, C.E. Griffiths, V. Sarma, R.S. Mitra, J.T. Elder, S.L. Kunkel, and V.M. Dixit. 1991. Cellular localization of interleukin-8 and its inducer, tumor necrosis factor-alpha in psoriasis. Am. J. Pathol. 138:129-140.
37. Perides, G., R.M. Safran, L.A. Downing, and M.E. Charness. 1994. Regulation of neural cell adhesion molecule and L1 by the transforming growth factor-beta superfamily. Selective effects of the bone morphogenetic proteins. J. Biol. Chem. 269:765-770.
38. Roop, D.R., C.K. Cheng, L. Titterington, C.A. Meyers, J.R. Stanley, P.M. Steinert, and S.H. Yuspa. 1984. Synthetic peptides corresponding to keratin subunits elicit highly specific antibodies. J. Biol. Chem. 259:8037-8040.
39. Sato, Y., R. Tsuboi, R. Lyons, H. Moses, and D.B. Rifkin. 1990. Characterization of the activation of latent TGF-beta by co-cultures of endothelial cells and pericytes or smooth muscle cells: a self-regulating system. J. Cell Biol. 111:757-763.
40. Schluesener, H.J., and R. Meyermann. 1994. Expression of BMP-6, a TGF-beta related morphogenetic cytokine, in rat radial glial cells. Glia. 12:161-164.
41. Schluesener, H.J., and R. Meyermann. 1995. Immunolocalization of BMP-6, a novel TGF-beta-related cytokine, in normal and atherosclerotic smooth muscle cells. Atherosclerosis. 113:153-156.
42. Schluesener, H.J., R. Meyermann, and S. Jung. 1995. Immunolocalization of vgr (BMP-6, DVR-6), a TGF-beta related cytokine, to Schwann cells of the rat peripheral nervous system: expression patterns are not modulated by autoimmune disease. Glia. 13:75-78.
43. Sellheyer, K., J.R. Bickenbach, J.A. Rothnagel, D. Bundman, M.A. Longley, T. Krieg, N.S. Roche, A.B. Roberts, and D.R. Roop. 1993. Inhibition of skin development by overexpression of transforming growth factor beta1 in the epidermis of transgenic mice. Proc. Natl. Acad. Sci. USA. 90:5237-5241.
44. Skerrow, D., and C.J. Skerrow. 1983. Tonofilament differentiation in human epidermis: isolation and polypeptide chain composition of keratinocyte subpopulation. Exp. Cell Res. 143:27-35.
45. Stoler, A., R. Kopan, M. Duvic, and E. Fuchs. 1988. The use of monospecific antibodies and cRNA probes reveals abnormal pathways of differentiation in human epidermal diseases. J. Cell Biol. 107:427-446.
46. Tomizawa, K., H. Matsui, E. Kondo, K. Miyamoto, M. Tokuda, T. Itano, S. Nagahata, T. Akagi, and O. Hatase. 1995. Developmental alteration and neuron-specific expression of bone morphogenetic protein-6 (BMP-6) mRNA in rodent brain. Brain Research and Molecular Brain Research. 28:122-128.
47. Tseng, S.C.G., M.J. Jarvinen, W.G. Nelson, J.-W. Huang, J. Woodcock-Mitchell, and T.-T. Sun. 1982. Correlation of specific keratins with different types of epithelial differentiation: monoclonal antibody studies. Cell. 30:361-372.
48. Turksen K., T. Kupper, L. Degenstein, I. Williams, and E. Fuchs. 1992. Interleukin 6: insights to its function in skin by overexpression in transgenic mice. Proc. Natl. Acad. Sci. USA. 89:5068-5072.
49. Vassar, R., and E. Fuchs. 1991. Transgenic mice provide new insights into the role of TGF-alpha during epidermal differentiation and development. Genes Dev. 5:714-727.
50. Wade, T.R., and M.C. Finan. 1990. Psoriaform dermatitis. In Pathology of the Skin, E.R. Farmer and A.F. Hood, editors. Appleton & Lange. Norwalk, Connecticut/San Mateo, California. 79-97.
51. Wall, N.A., M. Blessing, C.V.F., Wright, and B.L.M. Hogan. 1993. Biosynthesis and in vivo localization of the Decapentaplegic-Vg related protein, DVR-6 (bone morphogenetic protein-6). J. Cell Biol. 120:493-502.
52. Watt, F.M., and M.D. Hertle. 1994. Keratinocyte integrins. In The Keratinocyte Handbook. I.M. Leigh, E.B. Lane, and F.M. Watt, editors. Cambridge University Press, Cambridge, UK. 153-164.
53. Weinstein, G.G., and E.J. Van Scott. 1965. Autoradiographic analysis of turnover times of normal and psoriatic epidermis. J. Invest. Dermatol. 45:257-265.
54. Weiss, R.A., R.A. Eichner, and T.-T. Sun. 1984. Monoclonal antibody analysis of keratin expression in epidermal diseases: a 48- and 56-kilodatlon keratin as molecular markers for hyperproliferative keratinocytes. J. Cell Biol. 98: 1397-1406.
55. Werner, S., W. Weinberg, X. Liao, K.G. Peters, M. Blessing, S.H. Yuspa, R.L. Weiner, and L.T. Williams. 1993. Targeted expression of a dominant negative FGF receptor mutant in the epidermis of transgenic mice reveals a role of FGF in keratinocyte organization and differentiation. EMBO (Eur. Mol. Biol. Organ.) J. 12:2635-2643.
56. Woodcock-Mitchell, J., R. Eichner, W.G. Nelson, and T.-T. Sun. 1982. Immunolocalization of keratin polypeptides in human epidermis using monoclonal antibodies. J. Cell Biol. 95:580-588.
57. Wozney, J., V. Rosen, A.J. Celeste, L.M. Mitsock, M.J. Whitters, R.W. Kriz, R.M. Hewick, and E.A. Wang. 1988. Novel regulators of bone formation: molecular clones and activities. Science (Wash. DC). 242:1528-1534.
58. 6 heterodimer in normal human keratinocytes: implications for wound healing. J. Cell Biol. 129:853-865.